Garry E Menzel Insider Trading $STOK Stoke Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Garry E Menzel.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Garry E Menzel. Garry E Menzel is COO & Executive VP, Finance in Regulus Therapeutics Inc. ($RGLS) and Director in Stoke Therapeutics, Inc. ($STOK) and Director in Black Diamond Therapeutics, Inc. ($BDTX) and President & CEO in TCR2 THERAPEUTICS INC. ($TCRR) and President and CEO in TCR2 THERAPEUTICS INC. ($TCRR).

Garry E Menzel in Stoke Therapeutics, Inc.

Trading Symbol: STOK
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Garry E Menzel: Director
Holdings: 0 shares
Latest Transaction: Jan 27 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Garry E Menzel in Stoke Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, BDTX, RGLS, STOK, TCRR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 27 2021STOKStoke Therapeutics ...Menzel Garry EDirectorOption ExerciseA28.5729,555844,38629,555

Page:   1